Correction: IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway (International Immunology (2012) 24:10 (605-612) DOI: 10.1093/intimm/dxs056);Il-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway

International Immunology

Volumn 24, Issue 10, 2012, Pages 605-612

  Liu, Yanfang ^a,b   Zhu, Haitao ^a   Su, Zhaoliang ^a   Sun, Caixia ^c   Yin, Jingping ^a   Yuan, Hongyan ^a   Sandoghchian, Siamak ^a   Jiao, Zhijun ^c   Wang, Shengjun ^a   Xu, Huaxi ^a  

^a JIANGSU UNIVERSITY   (China)

^b First People's Hospital of Zhenjiang   (China)

^c AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Cardiac fibrosis; Experimental autoimmune myocarditis; IL 17

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR A; INTERLEUKIN 17 RECEPTOR C; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; HEART MUSCLE FIBROSIS; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MYOCARDITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84867137037     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxac063     Document Type: Erratum

References (36)

1. Blauwet, L. A. and Cooper, L. T. 2010. Myocarditis. Prog. Cardiovasc. Dis. 52:274.
2. Cihakova, D. and Rose, N. R. 2008. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99:95.
3. Fu, M. and Matsui, S. 2002. Is cardiomyopathy an autoimmune disease? Keio J. Med. 51:208.
4. h17 cells. Annu. Rev. Immunol. 27:485.
5. Wang, L., Chen, S. and Xu, K. 2011. IL-17 expression is correlated with hepatitis B related liver diseases and fibrosis. Int. J. Mol. Med. 27:385.
6. Wilson, M. S., Madala, S. K., Ramalingam, T. R. et al. 2010. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207:535.
7. Baldeviano, G. C., Barin, J. G., Talor, M. V. et al. 2010. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 106:1646.
8. Chang, H., Hanawa, H., Yoshida, T. et al. 2008. Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer. Circ. J. 72:813.
9. h17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol. 180:2686.
10. Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G. and Craig, S. W. 1987. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139:3630.
11. Rose, N. R., Wolfgram, L. J., Herskowitz, A. and Beisel, K. W. 1986. Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis. Ann. N. Y. Acad. Sci. 475:146.
12. Rose, N. R. 2009. Myocarditis: infection versus autoimmunity. J. Clin. Immunol. 29:730.
13. Afanasyeva, M., Georgakopoulos, D. and Rose, N. R. 2004. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun. Rev. 3:476.
14. Eriksson, U., Kurrer, M. O., Schmitz, N. et al. 2003. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 107:320.
15. h17 immunity. Autoimmunity 41:490.
16. Fumo, P., Kuncio, G. S. and Ziyadeh, F. N. 1994. PKC and high glucose stimulate collagen alpha 1 (IV) transcriptional activity in a reporter mesangial cell line. Am. J. Physiol. 267:F632.
17. Hehenberger, K., Hansson, A., Heilborn, J. D., Abdel-Halim, S. M., Ostensson, C. G. and Brismar, K. 1999. Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus. Wound Repair Regen. 7:65.
18. Zhu, J. and Paul, W. E. 2008. CD4 T cells: fates, functions, and faults. Blood 112:1557.
19. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337.
20. Park, H., Li, Z., Yang, X. O. et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133.
21. h17. J. Exp. Med. 205:1517.
22. h17-cell expansion. Eur. J. Immunol. 41:3586-3595.
23. Chen, P., Xie, Y., Shen, E. et al. 2011. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-beta1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur. J. Pharmacol. 658:168.
24. Kapur, N. K. 2011. Transforming growth factor-beta: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular function. Circ. Heart Fail. 4:5.
25. Melendez, G. C., McLarty, J. L., Levick, S. P., Du, Y., Janicki, J. S. and Brower, G. L. 2010. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56:225.
26. Aujla, S. J., Dubin, P. J. and Kolls, J. K. 2007. Interleukin-17 in pulmonary host defense. Exp. Lung Res. 33:507.
27. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607.
28. Wakasaki, H., Koya, D., Schoen, F. J. et al. 1997. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc. Natl Acad. Sci. USA 94: 9320.
29. Inoguchi, T., Battan, R., Handler, E., Sportsman, J. R., Heath, W. and King, G. L. 1992. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. USA 89:11059.
30. Ishii, H., Jirousek, M. R., Koya, D. et al. 1996. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728.
31. Kuestner, R. E., Taft, D. W., Haran, A. et al. 2007. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179:5462.
32. Toy, D., Kugler, D., Wolfson, M. et al. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177:36.
33. Hu, Y., Ota, N., Peng, I. et al. 2010. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184: 4307.
34. Feng, W., Li, W., Liu, W., Wang, F., Li, Y. and Yan, W. 2009. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp. Mol. Pathol. 87:212.
35. Cooper, L. T. Jr 2009. Myocarditis. N. Engl. J. Med. 360:1526.
36. Frustaci, A., Russo, M. A. and Chimenti, C. 2009. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur. Heart J. 30:1995.